A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Bristol-Myers Squibb
Bristol-Myers Squibb
Eli Lilly and Company
Pfizer
Verastem, Inc.
Pfizer
Trishula Therapeutics, Inc.
Actuate Therapeutics Inc.
Canadian Cancer Trials Group
Northwestern University
Celgene
Masonic Cancer Center, University of Minnesota
Northwestern University
Amgen
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)